Tuberculosis in Patients With End-Stage Renal Disease Undergoing Dialysis in an Endemic Region of Turkey

Transplantation Proceedings

Volumn 40, Issue 1, 2008, Pages 81-84

  Sen, N ^a   Turunc, T ^a   Karatasli, M ^a   Sezer, S ^a   Demiroglu, Y Z ^a   Oner Eyuboglu, F ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; MORPHOZINAMIDE; OFLOXACIN; PYRIDOXINE; RIFAMPICIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLURRED VISION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIALYSIS; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE REDUCTION; ENDEMIC DISEASE; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INFECTION RISK; JAUNDICE; KIDNEY FAILURE; LIVER TOXICITY; LUNG DISEASE; LUNG TUBERCULOSIS; MALE; MORTALITY; MULTIDRUG RESISTANCE; OPTIC NEURITIS; PRIORITY JOURNAL; PSYCHOPATHY; SIDE EFFECT; TREATMENT RESPONSE; TURKEY (REPUBLIC); UNSPECIFIED SIDE EFFECT; VISUAL IMPAIRMENT;

ADULT; AGED; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS; TIME FACTORS; TUBERCULOSIS; TURKEY;

EID: 38749106570     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.12.003     Document Type: Article

References (21)

1. Hussein M.M., Mooij J.M., and Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial 16 (2003) 38
2. Cengiz K. Increased incidence of tuberculosis in patients undergoing hemodialysis. Nephron 73 (1996) 421
3. Andrew O.T., Schoenfeld P.Y., Hopewell P.C., et al. Tuberculosis in patients with end-stage renal disease. Am J Med 68 (1980) 59
4. Shohaib S.A., Scrimgeour E.M., and Shaerya F. Tuberculosis in active dialysis patients in Jeddah. Am J Nephrol 19 (1999) 34
5. Quantrill S.J., Woodhead M.A., Bell C.E., et al. Side-effects of antituberculosis drug treatment in patients with chronic renal failure. Eur Respir J 20 (2002) 440
6. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO Report 2007 (2007), WHO, Geneva (WHO/HTM/TB 2007.376)
7. Centers for Disease Control and Prevention (CDC). Trends in tuberculosis-United States, 2005. MMWR Morb Mortal Wkly Rep 55 (2006) 305
8. Gumuslu F., Ozkara S., Ozkan S., et al. Turkiye'de verem savasi, 2007 raporu. Verem Savas Daire Baskanligi, Ankara (2007)
9. Skerrett S.J., Niederman M.S., and Fein A.M. Respiratory infections and acute lung injury in systemic illness. Clin Chest Med 10 (1989) 469
10. Freeman R., Newhouse C.E., and Lawton R.L. Letter: absence of tuberculosis in dialysis patients. JAMA 233 (1975) 1356
11. Hsu K.T., Lam K.K., Liao S.C., et al. Prevalence of pulmonary tuberculosis in end-stage renal disease (ESRD) patients is not unusually high. Clin Nephrol 45 (1996) 279
12. Taskapan H., Utas C., Oymak F.S., et al. The outcome of tuberculosis in patients on chronic hemodialysis. Clin Nephrol 54 (2000) 134
13. Abdelrahman M., Sinha A.K., and Karkar A. Tuberculosis in end-stage renal disease patients on hemodialysis. Hemodial Int 10 (2006) 360
14. Chou K.J., Fang H.C., Bai K.J., et al. Tuberculosis in maintenance dialysis patients. Nephron 88 (2001) 138
15. Oner-Eyuboglu A.F., Akcay M.S., Arslan H., et al. Extrapulmonary involvement of mycobacterial infections in dialysis patients. Transplant Proc 31 (1999) 3199
16. Mitwalli A. Tuberculosis in patients on maintenance dialysis. Am J Kidney Dis 18 (1991) 579
17. Chia S., Karim M., Elwood R.K., et al. Risk of tuberculosis in dialysis patients: a population-based study. Int J Tuberc Lung Dis 2 (1998) 989
18. Al-Homrany M. Successful therapy of tuberculosis in hemodialysis patients. Am J Nephrol 17 (1997) 32
19. Fang J.T., Chen Y.C., and Chang M.Y. Ethambutol-induced optic neuritis in patients with end stage renal disease on hemodialysis: two case reports and literature review. Ren Fail 26 (2004) 189
20. Blumberg H.M., Burman W.J., Chaisson R.E., et al., American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 167 (2003) 603
21. Siskind M.S., Thienemann D., and Kirlin L. Isoniazid-induced neurotoxicity in chronic dialysis patients: report of three cases and a review of the literature. Nephron 64 (1993) 303